Erik Portelius Selected Research

Brevican

5/2021	Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.
1/2021	Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.
1/2021	Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
9/2019	Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik Portelius Research Topics

Disease

96	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2004
16	Cognitive Dysfunction 01/2021 - 04/2008
13	Dementia (Dementias) 01/2022 - 10/2015
12	Amyloid Plaque 10/2021 - 01/2009
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 01/2009
4	Down Syndrome (Down's Syndrome) 01/2022 - 01/2014
4	Normal Pressure Hydrocephalus 05/2021 - 09/2019
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 04/2017
4	Brain Injuries (Brain Injury) 01/2021 - 11/2015
4	Amyloidosis 12/2018 - 01/2014
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 04/2011
3	Disease Progression 01/2019 - 01/2012
3	Atrophy 12/2017 - 01/2013
2	Stroke (Strokes) 01/2022 - 01/2019
2	Trisomy (Trisomies) 01/2022 - 01/2018
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021 - 01/2016
2	Myocardial Infarction 01/2020 - 04/2011
2	Neuroinflammatory Diseases 01/2018 - 12/2015
2	Tauopathies 01/2017 - 03/2016
2	Memory Disorders (Memory Loss) 03/2016 - 12/2012
2	Frontotemporal Dementia (Semantic Dementia) 03/2016 - 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Gliosis 01/2019
1	Ischemic Stroke 01/2019
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	familial Danish Dementia 01/2018
1	Chromosome 3-Linked Frontotemporal Dementia 01/2018
1	Bacterial Meningitis 01/2017
1	Chronic Traumatic Encephalopathy 11/2016
1	Neurobehavioral Manifestations 11/2016
1	Post-Concussion Syndrome 11/2016
1	Lewy Body Disease (Lewy Body Dementia) 03/2016
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 03/2016
1	Multiple System Atrophy 03/2016
1	Synucleinopathies 03/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2014
1	Multiple Sclerosis 04/2013
1	Neoplasms (Cancer) 04/2013
1	Inflammation (Inflammations) 12/2012
1	Skin Neoplasms (Skin Cancer) 11/2012

Drug/Important Bio-Agent (IBA)

59	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2004
44	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
36	Peptides (Polypeptides)IBA 01/2022 - 01/2004
31	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
21	Amyloid beta-PeptidesIBA 01/2021 - 04/2006
10	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020 - 01/2009
10	Amino Acids FDA Link 01/2020 - 04/2006
10	NeurograninIBA 01/2019 - 01/2015
9	Protein Isoforms (Isoforms)IBA 02/2014 - 01/2009
8	EnzymesIBA 01/2019 - 03/2010
7	Pharmaceutical PreparationsIBA 10/2021 - 09/2009
4	BrevicanIBA 05/2021 - 09/2019
4	NeurocanIBA 05/2021 - 09/2019
4	Flavin-Adenine Dinucleotide (FAD)IBA 01/2021 - 01/2018
4	ImmunosorbentsIBA 01/2019 - 10/2015
3	tau Proteins (tau Protein)IBA 01/2022 - 07/2015
3	Extracellular Matrix ProteinsIBA 05/2021 - 01/2019
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018 - 01/2015
2	Presenilin-1IBA 01/2021 - 01/2013
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 11/2015 - 11/2012
2	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2015 - 03/2012
1	Complement System Proteins (Complement)IBA 01/2022
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2020
1	TroponinIBA 01/2020
1	asparaginylendopeptidase (legumain)IBA 01/2020
1	tenascin RIBA 09/2019
1	TenascinIBA 09/2019
1	polyacrylamideIBA 01/2019
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2019
1	SodiumIBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	Tissue ExtractsIBA 12/2018
1	visininIBA 06/2017
1	Chitinase-3-Like Protein 1IBA 06/2017
1	flutemetamolIBA 11/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2015
1	Peptide FragmentsIBA 05/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015
1	Selegiline (E250)FDA LinkGeneric 01/2015
1	DeuteriumIBA 01/2015
1	Apolipoproteins E (ApoE)IBA 02/2014
1	2- (5- chloro- 6- (2,2,2- trifluoroethoxy)- 4'- (trifluoromethyl)biphenyl- 3- yl)- 3- cyclobutylpropanoic acidIBA 12/2012
1	BMS 708163IBA 11/2012
1	PresenilinsIBA 04/2012
1	Chromogranin BIBA 01/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2011
1	Troponin T (Troponin T1)IBA 04/2011
1	EpitopesIBA 01/2011
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 03/2010
1	formic acid (formate)IBA 09/2009
1	Biological ProductsIBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2012
1	Embolectomy 01/2022